United States Healthcare Providers & Services

Quest Diagnostics Inc (DGX)

Track

Over the past 90 days, Quest Diagnostics insiders have engaged in five transactions, all involving sales totaling approximately $7.5 million. These activities occurred alongside a 23% stock price increase. Following the company's July 2026 earnings report, which showed an 11% EPS beat, executives continue to execute planned and proposed sales of their holdings.

Recent historical selling signal · Mar 2026

Not featured in screeners

Featured in screeners

Recent historical selling signal · Mar 2026

Not featured in screeners

Ticker: DGX Exchange: NYS

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signal detected

18 activity signals detected for Quest Diagnostics Inc

Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Quest Diagnostics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Planned sale 28 Jul 2026

Value US$4,913,725.49 | Price 200.44 | Shares 73,395 (-33.4%)

Proposed sale 28 Jul 2026

Value US$1,714,929.65 | Price 429.32 | Shares 55,185

Planned sale 4 Jun 2026

Value US$939,895.51 | Price 439.01 | Shares 73,805 (-36.0%)

Proposed sale 4 Jun 2026

Value US$212,670.36 | Price 451.45 | Shares 19,287

Planned sale 1 Jun 2026

Value US$1,941,400.00 | Price 194.14 | Shares 10,000 (-7.0%)

Proposed sale 1 Jun 2026

Value US$1,941,360.00 | Price 194.14 | Shares 10,000

Planned sale 5 Mar 2026

Value US$799,682.38 | Price 206.21 | Shares 3,878 (-9.4%)

Proposed sale 5 Mar 2026

Value US$799,682.38 | Price 206.21 | Shares 3,878

Planned sale 5 Mar 2026

Value US$588,729.55 | Price 206.21 | Shares 2,855 (-15.8%)

Proposed sale 5 Mar 2026

Value US$588,729.55 | Price 206.21 | Shares 2,855

Planned sale 5 Mar 2026

Value US$1,146,115.18 | Price 206.21 | Shares 5,558 (-7.6%)

Proposed sale 5 Mar 2026

Value US$1,146,115.18 | Price 206.21 | Shares 5,558

Sale 4 Mar 2026

Value US$538,372.08 | Price 204.86 | Shares 2,628 (-16.4%)

Planned sale 3 Mar 2026

Value US$109,265.98 | Price 207.73 | Shares 526 (-1.4%)

Proposed sale 3 Mar 2026

Value US$109,265.98 | Price 207.73 | Shares 526

Planned sale 3 Mar 2026

Value US$131,285.36 | Price 207.73 | Shares 632 (-0.9%)

Proposed sale 3 Mar 2026

Value US$131,285.36 | Price 207.73 | Shares 632

Planned sale 3 Mar 2026

Value US$85,169.30 | Price 207.73 | Shares 410 (-2.6%)

Proposed sale 3 Mar 2026

Value US$85,169.30 | Price 207.73 | Shares 410

Planned sale 2 Mar 2026

Value US$2,125,200.00 | Price 212.52 | Shares 10,000 (-7.9%)

Proposed sale 2 Mar 2026

Value US$2,125,200.00 | Price 212.52 | Shares 10,000

Planned sale 19 Feb 2026

Value US$196,227.14 | Price 204.83 | Shares 958 (-5.7%)

Proposed sale 19 Feb 2026

Value US$196,227.14 | Price 204.83 | Shares 958

Planned sale 19 Feb 2026

Value US$227,566.13 | Price 204.83 | Shares 1,111 (-2.8%)

Proposed sale 19 Feb 2026

Value US$227,566.13 | Price 204.83 | Shares 1,111

Planned sale 19 Feb 2026

Value US$293,521.39 | Price 204.83 | Shares 1,433 (-2.1%)

Proposed sale 19 Feb 2026

Value US$293,521.39 | Price 204.83 | Shares 1,433

Planned sale 13 Feb 2026

Value US$73,394.94 | Price 209.10 | Shares 351 (-0.5%)

Planned sale 13 Feb 2026

Value US$337,093.12 | Price 208.21 | Shares 1,619 (-2.3%)

Planned sale 13 Feb 2026

Value US$724,787.70 | Price 207.08 | Shares 3,500 (-4.8%)

Planned sale 13 Feb 2026

Value US$2,088,883.21 | Price 206.37 | Shares 10,122 (-12.1%)

Planned sale 13 Feb 2026

Value US$2,169,655.73 | Price 205.21 | Shares 10,573 (-11.2%)

Proposed sale 13 Feb 2026

Value US$5,428,714.20 | Price 207.48 | Shares 26,165

Planned sale 10 Feb 2026

Value US$1,155,048.00 | Price 204.00 | Shares 5,662 (-26.9%)

Proposed sale 10 Feb 2026

Value US$1,155,048.00 | Price 204.00 | Shares 5,662

Sale 25 Nov 2025

Value US$239,700.00 | Price 191.76 | Shares 1,250 (-6.8%)

Proposed sale 25 Nov 2025

Value US$239,700.00 | Price 191.76 | Shares 1,250

Planned sale 25 Nov 2025

Value US$916,036.66 | Price 192.97 | Shares 4,747 (-3.8%)

Planned sale 25 Nov 2025

Value US$7,883,900.59 | Price 192.27 | Shares 41,004 (-24.7%)

Planned sale 25 Nov 2025

Value US$1,789,822.57 | Price 191.59 | Shares 9,342 (-5.3%)

Proposed sale 25 Nov 2025

Value US$10,589,761.55 | Price 192.22 | Shares 55,093

Planned sale 18 Nov 2025

Value US$1,488,683.10 | Price 187.35 | Shares 7,946 (-51.3%)

Proposed sale 18 Nov 2025

Value US$1,488,683.10 | Price 187.35 | Shares 7,946

Sale 22 Oct 2025

Value US$270,316.80 | Price 182.40 | Shares 1,482 (-4.8%)

Proposed sale 22 Oct 2025

Value US$270,316.80 | Price 182.40 | Shares 1,482

Planned sale 26 Sep 2025

Value US$27,166.77 | Price 188.66 | Shares 144 (-0.4%)

Planned sale 26 Sep 2025

Value US$15,539.24 | Price 187.22 | Shares 83 (-0.2%)

Proposed sale 26 Sep 2025

Value US$42,706.00 | Price 188.13 | Shares 227

Planned sale 24 Sep 2025

Value US$32,729.02 | Price 187.02 | Shares 175 (-0.5%)

Proposed sale 24 Sep 2025

Value US$32,729.03 | Price 187.02 | Shares 175

Planned sale 23 Sep 2025

Value US$5,293,312.79 | Price 187.12 | Shares 28,288 (-42.6%)

Proposed sale 23 Sep 2025

Value US$5,293,313.43 | Price 187.12 | Shares 28,288

Planned sale 21 Aug 2025

Value US$365,375.00 | Price 185.00 | Shares 1,975 (-11.5%)

Proposed sale 21 Aug 2025

Value US$365,375.00 | Price 185.00 | Shares 1,975

Planned sale 19 Aug 2025

Value US$829,356.00 | Price 183.00 | Shares 4,532 (-20.8%)

Proposed sale 19 Aug 2025

Value US$829,356.00 | Price 183.00 | Shares 4,532

Planned sale 15 Aug 2025

Value US$355,500.00 | Price 180.00 | Shares 1,975 (-10.3%)

Proposed sale 15 Aug 2025

Value US$12,960.00 | Price 180.00 | Shares 72

Proposed sale 15 Aug 2025

Value US$342,540.00 | Price 180.00 | Shares 1,903

Planned sale 6 Aug 2025

Value US$345,625.00 | Price 175.00 | Shares 1,975 (-9.3%)

Planned sale 6 Aug 2025

Value US$623,000.00 | Price 175.00 | Shares 3,560 (-14.4%)

Proposed sale 6 Aug 2025

Value US$968,625.00 | Price 175.00 | Shares 5,535

Planned sale 31 Jul 2025

Value US$375,700.00 | Price 170.00 | Shares 2,210 (-20.7%)

Proposed sale 31 Jul 2025

Value US$375,700.00 | Price 170.00 | Shares 2,210

Planned sale 30 Jul 2025

Value US$874,497.60 | Price 167.40 | Shares 5,224 (-32.9%)

Planned sale 30 Jul 2025

Value US$509,733.00 | Price 167.40 | Shares 3,045 (-22.2%)

Proposed sale 30 Jul 2025

Value US$1,384,230.60 | Price 167.40 | Shares 8,269

Planned sale 13 May 2025

Value US$153,220.94 | Price 175.31 | Shares 874 (-10.4%)

Proposed sale 13 May 2025

Value US$153,220.94 | Price 175.31 | Shares 874

Planned sale 12 May 2025

Value US$153,579.28 | Price 175.72 | Shares 874 (-9.5%)

Proposed sale 12 May 2025

Value US$153,579.28 | Price 175.72 | Shares 874

Planned sale 2 Apr 2025

Value US$76,844.20 | Price 169.63 | Shares 453 (-0.4%)

Planned sale 2 Apr 2025

Value US$152,249.48 | Price 168.79 | Shares 902 (-0.7%)

Planned sale 2 Apr 2025

Value US$250,642.75 | Price 167.88 | Shares 1,493 (-1.1%)

Planned sale 2 Apr 2025

Value US$45,282.45 | Price 169.60 | Shares 267 (-0.2%)

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2026-07-29	2026-07-28	PlS Planned sale	3.0 DELANEY MARK E SVP & Chief Commercial Officer Officer	73,395 -33.4% 200.44 US$4,913,725	73,395 -33.4%	200.44	US$4,913,725
2026-07-28	2026-07-28	PrS Proposed sale	3.0 DELANEY MARK E Officer Officer	55,185 429.32 US$1,714,930	55,185	429.32	US$1,714,930
2026-06-08	2026-06-04	PlS Planned sale	2.3 KUPPUSAMY KARTHIK SVP, Clinical Solutions Officer	73,805 -36.0% 439.01 US$939,896	73,805 -36.0%	439.01	US$939,896
2026-06-04	2026-06-04	PrS Proposed sale	2.3 KUPPUSAMY KARTHIK Officer Officer	8,147 200.00 US$1,629,400	8,147	200.00	US$1,629,400
2026-06-02	2026-06-01	PlS Planned sale	Davis J. E. CEO and President Executive Director	10,000 -7.0% 194.14 US$1,941,400	10,000 -7.0%	194.14	US$1,941,400
2026-06-01	2026-06-01	PrS Proposed sale	Davis J. E. Officer; Director Executive Director	10,000 194.14 US$1,941,360	10,000	194.14	US$1,941,360
2026-03-06	2026-03-05	PlS Planned sale	2.7 PREVOZNIK MICHAEL E SVP & General Counsel Officer	3,878 -9.4% 206.21 US$799,682	3,878 -9.4%	206.21	US$799,682
2026-03-06	2026-03-05	PlS Planned sale	1.5 Plewman Patrick SVP for Diagnostic Services Officer	2,855 -15.8% 206.21 US$588,730	2,855 -15.8%	206.21	US$588,730
2026-03-06	2026-03-05	PlS Planned sale	1.5 Doherty Catherine T. EVP, Regional Businesses Officer	5,558 -7.6% 206.21 US$1,146,115	5,558 -7.6%	206.21	US$1,146,115
2026-03-05	2026-03-05	PrS Proposed sale	2.7 PREVOZNIK MICHAEL E Officer Officer	3,878 206.21 US$799,682	3,878	206.21	US$799,682
2026-03-05	2026-03-05	PrS Proposed sale	1.5 Doherty Catherine T. Officer Officer	5,558 206.21 US$1,146,115	5,558	206.21	US$1,146,115
2026-03-05	2026-03-05	PrS Proposed sale	1.5 Plewman Patrick Officer Officer	2,855 206.21 US$588,730	2,855	206.21	US$588,730
2026-03-06	2026-03-04	S Sale	2.3 KUPPUSAMY KARTHIK SVP, Clinical Solutions Officer	2,628 -16.4% 204.86 US$538,372	2,628 -16.4%	204.86	US$538,372
2026-03-04	2026-03-03	PlS Planned sale	2.7 PREVOZNIK MICHAEL E SVP & General Counsel Officer	526 -1.4% 207.73 US$109,266	526 -1.4%	207.73	US$109,266
2026-03-04	2026-03-03	PlS Planned sale	1.5 Doherty Catherine T. EVP, Regional Businesses Officer	632 -0.9% 207.73 US$131,285	632 -0.9%	207.73	US$131,285
2026-03-04	2026-03-03	PlS Planned sale	1.5 Plewman Patrick SVP for Diagnostic Services Officer	410 -2.6% 207.73 US$85,169	410 -2.6%	207.73	US$85,169
2026-03-03	2026-03-03	PrS Proposed sale	1.5 Doherty Catherine T. Officer Officer	632 207.73 US$131,285	632	207.73	US$131,285
2026-03-03	2026-03-03	PrS Proposed sale	2.7 PREVOZNIK MICHAEL E Officer Officer	526 207.73 US$109,266	526	207.73	US$109,266
2026-03-03	2026-03-03	PrS Proposed sale	1.5 Plewman Patrick Officer Officer	410 207.73 US$85,169	410	207.73	US$85,169
2026-03-04	2026-03-02	PlS Planned sale	Davis J. E. CEO and President Executive Director	10,000 -7.9% 212.52 US$2,125,200	10,000 -7.9%	212.52	US$2,125,200
2026-03-02	2026-03-02	PrS Proposed sale	Davis J. E. Officer; Director Executive Director	10,000 212.52 US$2,125,200	10,000	212.52	US$2,125,200
2026-02-20	2026-02-19	PlS Planned sale	1.5 Plewman Patrick SVP for Diagnostic Services Officer	958 -5.7% 204.83 US$196,227	958 -5.7%	204.83	US$196,227
2026-02-20	2026-02-19	PlS Planned sale	2.7 PREVOZNIK MICHAEL E SVP & General Counsel Officer	1,111 -2.8% 204.83 US$227,566	1,111 -2.8%	204.83	US$227,566
2026-02-20	2026-02-19	PlS Planned sale	1.5 Doherty Catherine T. EVP, Regional Businesses Officer	1,433 -2.1% 204.83 US$293,521	1,433 -2.1%	204.83	US$293,521
2026-02-19	2026-02-19	PrS Proposed sale	1.5 Plewman Patrick Officer Officer	958 204.83 US$196,227	958	204.83	US$196,227
2026-02-19	2026-02-19	PrS Proposed sale	1.5 Doherty Catherine T. Officer Officer	1,433 204.83 US$293,521	1,433	204.83	US$293,521
2026-02-19	2026-02-19	PrS Proposed sale	2.7 PREVOZNIK MICHAEL E Officer Officer	1,111 204.83 US$227,566	1,111	204.83	US$227,566
2026-02-17	2026-02-13	PlS Planned sale	1.5 Doherty Catherine T. EVP, Regional Businesses Officer	351 -0.5% 209.10 US$73,395	351 -0.5%	209.10	US$73,395
2026-02-17	2026-02-13	PlS Planned sale	1.5 Doherty Catherine T. EVP, Regional Businesses Officer	1,619 -2.3% 208.21 US$337,093	1,619 -2.3%	208.21	US$337,093
2026-02-17	2026-02-13	PlS Planned sale	1.5 Doherty Catherine T. EVP, Regional Businesses Officer	3,500 -4.8% 207.08 US$724,788	3,500 -4.8%	207.08	US$724,788
2026-02-17	2026-02-13	PlS Planned sale	1.5 Doherty Catherine T. EVP, Regional Businesses Officer	10,122 -12.1% 206.37 US$2,088,883	10,122 -12.1%	206.37	US$2,088,883
2026-02-17	2026-02-13	PlS Planned sale	1.5 Doherty Catherine T. EVP, Regional Businesses Officer	10,573 -11.2% 205.21 US$2,169,656	10,573 -11.2%	205.21	US$2,169,656
2026-02-13	2026-02-13	PrS Proposed sale	1.5 Doherty Catherine T. Officer Officer	26,165 207.48 US$5,428,714	26,165	207.48	US$5,428,714
2026-02-12	2026-02-10	PlS Planned sale	1.5 Plewman Patrick SVP for Diagnostic Services Officer	5,662 -26.9% 204.00 US$1,155,048	5,662 -26.9%	204.00	US$1,155,048
2026-02-10	2026-02-10	PrS Proposed sale	1.5 Plewman Patrick Officer Officer	5,662 204.00 US$1,155,048	5,662	204.00	US$1,155,048
2025-11-28	2025-11-25	S Sale	2.6 Gregg Vicky B Non-Executive Director	1,250 -6.8% 191.76 US$239,700	1,250 -6.8%	191.76	US$239,700
2025-11-28	2025-11-25	PlS Planned sale	Davis J. E. CEO and President Executive Director	4,747 -3.8% 192.97 US$916,037	4,747 -3.8%	192.97	US$916,037
2025-11-28	2025-11-25	PlS Planned sale	Davis J. E. CEO and President Executive Director	41,004 -24.7% 192.27 US$7,883,901	41,004 -24.7%	192.27	US$7,883,901
2025-11-28	2025-11-25	PlS Planned sale	Davis J. E. CEO and President Executive Director	9,342 -5.3% 191.59 US$1,789,823	9,342 -5.3%	191.59	US$1,789,823
2025-11-25	2025-11-25	PrS Proposed sale	Davis J. E. Officer; Director Executive Director	55,093 192.22 US$10,589,762	55,093	192.22	US$10,589,762
2025-11-25	2025-11-25	PrS Proposed sale	2.6 Gregg Vicky B Director Non-Executive Director	1,250 191.76 US$239,700	1,250	191.76	US$239,700
2025-11-20	2025-11-18	PlS Planned sale	3.0 DELANEY MARK E SVP & Chief Commercial Officer Officer	7,946 -51.3% 187.35 US$1,488,683	7,946 -51.3%	187.35	US$1,488,683
2025-11-18	2025-11-18	PrS Proposed sale	3.0 DELANEY MARK E Officer Officer	7,946 187.35 US$1,488,683	7,946	187.35	US$1,488,683
2025-10-24	2025-10-22	S Sale	0.9 PFEIFFER GARY M Non-Executive Director	1,482 -4.8% 182.40 US$270,317	1,482 -4.8%	182.40	US$270,317
2025-10-22	2025-10-22	PrS Proposed sale	0.9 PFEIFFER GARY M Director Non-Executive Director	1,482 182.40 US$270,317	1,482	182.40	US$270,317
2025-09-30	2025-09-26	PlS Planned sale	2.7 PREVOZNIK MICHAEL E SVP & General Counsel Officer	144 -0.4% 188.66 US$27,167	144 -0.4%	188.66	US$27,167
2025-09-30	2025-09-26	PlS Planned sale	2.7 PREVOZNIK MICHAEL E SVP & General Counsel Officer	83 -0.2% 187.22 US$15,539	83 -0.2%	187.22	US$15,539
2025-09-26	2025-09-26	PrS Proposed sale	2.7 PREVOZNIK MICHAEL E Officer Officer	227 188.13 US$42,706	227	188.13	US$42,706
2025-09-25	2025-09-24	PlS Planned sale	2.7 PREVOZNIK MICHAEL E SVP & General Counsel Officer	175 -0.5% 187.02 US$32,729	175 -0.5%	187.02	US$32,729
2025-09-24	2025-09-24	PrS Proposed sale	2.7 PREVOZNIK MICHAEL E Officer Officer	175 187.02 US$32,729	175	187.02	US$32,729
2025-09-25	2025-09-23	PlS Planned sale	2.7 PREVOZNIK MICHAEL E SVP & General Counsel Officer	28,288 -42.6% 187.12 US$5,293,313	28,288 -42.6%	187.12	US$5,293,313
2025-09-23	2025-09-23	PrS Proposed sale	2.7 PREVOZNIK MICHAEL E Officer Officer	28,288 187.12 US$5,293,313	28,288	187.12	US$5,293,313
2025-08-25	2025-08-21	PlS Planned sale	1.5 Plewman Patrick SVP for Diagnostic Services Officer	1,975 -11.5% 185.00 US$365,375	1,975 -11.5%	185.00	US$365,375
2025-08-21	2025-08-21	PrS Proposed sale	1.5 Plewman Patrick Officer Officer	1,975 185.00 US$365,375	1,975	185.00	US$365,375
2025-08-21	2025-08-19	PlS Planned sale	1.5 Plewman Patrick SVP for Diagnostic Services Officer	4,532 -20.8% 183.00 US$829,356	4,532 -20.8%	183.00	US$829,356
2025-08-19	2025-08-19	PrS Proposed sale	1.5 Plewman Patrick Director Non-Executive Director	4,532 183.00 US$829,356	4,532	183.00	US$829,356
2025-08-19	2025-08-15	PlS Planned sale	1.5 Plewman Patrick SVP for Diagnostic Services Officer	1,975 -10.3% 180.00 US$355,500	1,975 -10.3%	180.00	US$355,500
2025-08-15	2025-08-15	PrS Proposed sale	1.5 Plewman Patrick Officer Officer	72 180.00 US$12,960	72	180.00	US$12,960
2025-08-15	2025-08-15	PrS Proposed sale	1.5 Plewman Patrick Officer Officer	1,903 180.00 US$342,540	1,903	180.00	US$342,540
2025-08-08	2025-08-06	PlS Planned sale	1.5 Plewman Patrick SVP for Diagnostic Services Officer	1,975 -9.3% 175.00 US$345,625	1,975 -9.3%	175.00	US$345,625
2025-08-08	2025-08-06	PlS Planned sale	1.5 Plewman Patrick SVP for Diagnostic Services Officer	3,560 -14.4% 175.00 US$623,000	3,560 -14.4%	175.00	US$623,000
2025-08-06	2025-08-06	PrS Proposed sale	1.5 Plewman Patrick Officer Officer	5,535 175.00 US$968,625	5,535	175.00	US$968,625
2025-08-01	2025-07-31	PlS Planned sale	2.3 KUPPUSAMY KARTHIK SVP, Clinical Solutions Officer	2,210 -20.7% 170.00 US$375,700	2,210 -20.7%	170.00	US$375,700
2025-07-31	2025-07-31	PrS Proposed sale	2.3 KUPPUSAMY KARTHIK Officer Officer	2,210 170.00 US$375,700	2,210	170.00	US$375,700
2025-08-01	2025-07-30	PlS Planned sale	2.3 KUPPUSAMY KARTHIK SVP, Clinical Solutions Officer	5,224 -32.9% 167.40 US$874,498	5,224 -32.9%	167.40	US$874,498
2025-08-01	2025-07-30	PlS Planned sale	2.3 KUPPUSAMY KARTHIK SVP, Clinical Solutions Officer	3,045 -22.2% 167.40 US$509,733	3,045 -22.2%	167.40	US$509,733
2025-07-30	2025-07-30	PrS Proposed sale	2.3 KUPPUSAMY KARTHIK Officer Officer	8,269 167.40 US$1,384,231	8,269	167.40	US$1,384,231
2025-05-14	2025-05-13	PlS Planned sale	3.0 DELANEY MARK E SVP & Chief Commercial Officer Officer	874 -10.4% 175.31 US$153,221	874 -10.4%	175.31	US$153,221
2025-05-13	2025-05-13	PrS Proposed sale	3.0 DELANEY MARK E Officer Officer	874 175.31 US$153,221	874	175.31	US$153,221
2025-05-14	2025-05-12	PlS Planned sale	3.0 DELANEY MARK E SVP & Chief Commercial Officer Officer	874 -9.5% 175.72 US$153,579	874 -9.5%	175.72	US$153,579
2025-05-12	2025-05-12	PrS Proposed sale	3.0 DELANEY MARK E Officer Officer	874 175.72 US$153,579	874	175.72	US$153,579
2025-04-04	2025-04-02	PlS Planned sale	Davis J. E. CEO and President Executive Director	453 -0.4% 169.63 US$76,844	453 -0.4%	169.63	US$76,844
2025-04-04	2025-04-02	PlS Planned sale	Davis J. E. CEO and President Executive Director	902 -0.7% 168.79 US$152,249	902 -0.7%	168.79	US$152,249
2025-04-04	2025-04-02	PlS Planned sale	Davis J. E. CEO and President Executive Director	1,493 -1.1% 167.88 US$250,643	1,493 -1.1%	167.88	US$250,643
2025-04-04	2025-04-02	PlS Planned sale	Davis J. E. CEO and President Executive Director	267 -0.2% 169.60 US$45,282	267 -0.2%	169.60	US$45,282